Early Drop in Systolic BP Linked to Worse CV, Renal Function in Acute Heart Failure
Researchers examined the relationship between a drop in systolic BP, worsening renal function, and prognosis in people with acute heart failure.
All articles by Endocrinology Advisor Contributing Writer
Metformin May Improve Clinical Outcomes in Comorbid Heart Failure and Diabetes
Researchers assessed the clinical outcomes of patients with comorbid heart failure and diabetes receiving treatment with metformin and sulfonylurea.
Mental Stress Worsens Cardiovascular Outcomes in Coronary Heart Disease
Researchers compared the link between mental stress- or conventional stress-induced ischemia and adverse CV events in patients with coronary heart disease.
Younger Adults Admitted for Peripheral Vascular Disease With CV Comorbidities
Using 2 national cohorts 10 years apart, researchers compared the mean age of young adults, who were hospitalized for PVD with CV comorbidities and major adverse cardiac and cerebrovascular events.
RAAS Inhibition Reduces Mortality in Patients With COVID-19, Pre-Existing Hypertension
A team of researchers analyzed the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on patients with COVID-19 with preexisting hypertension.
Certain BP Treatments Less Effective in Patients With Diabetes
Investigators assessed the impact of diabetes mellitus on the efficacy of a low-dose, triple combination, polypill or standard care for the treatment of hypertension.
High Leptin Increases Mortality Risk in Stable Coronary Heart Disease
Researchers at AHA 2021 presented a study that sought to determine whether high leptin affects the risk for mortality or morbidity in patients with stable CHD.
Empagliflozin Improves Cardiovascular Outcomes for Those With CVD
Among patients with type 2 diabetes, empagliflozin showed greater benefits in patients with CVD vs without.
Hypertensive Crisis Hospitalizations Higher in Non-White Men Using Cannabis
Researchers at AHA 2021 presented a study that examined rates of hypertensive crisis in young cannabis users vs nonusers of different race and sex.
Cardiovascular Outcomes With SGLT2 Inhibitors in T2D Compared
A network meta-analysis was done to compare the effectiveness of SGLT2 inhibitors in participants with type 2 diabetes and cardiovascular risk factors.
- Loading...
Loading...
Next post in Type 2 Diabetes
Loading... 
Loading...